Publication

The FLT3 inhibitor tandutinib (formerly MLN518) has sequence-independent synergistic effects with cytarabine and daunorubicin

Journal Paper/Review - Aug 24, 2009

Schittenhelm Marcus, Kampa-Schittenhelm Kerstin, Yee Kevin W H, Heinrich Michael C